NCT00618202View on ClinicalTrials.gov

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Ulcerative Colitis
Interventions
DRUG

Balsalazide

Trial Locations (1)

77042

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00618202 - A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter